Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled Retrospective Study Evaluating ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

How you can make sure you get your RSV vaccine this winterThe UK is the first country to offer a RSV vaccine to help save the ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

RSV vaccine recommended for adults 60+ with health issues, infants under 19 months, and all healthy adults 75+. Helps prevent ...

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

With COVID-19 hospitalizations rising and flu and RSV on the horizon, experts say it’s time to boost up your immunity ahead of the fall and winter season. Here are answers to some frequently ...

Respiratory syncytial virus, which infects nearly everyone by age 2, usually goes unnoticed because it mostly causes a common cold. But RSV is a leading cause of hospitalizations among newborns ...

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

RSV infections of the lungs and airways send up to 160,000 older adults to the hospital each year, at an annual cost of more than $1.3 billion, according to the Michigan Medicine report.